Moody Lynn & Lieberson LLC Boosts Holdings in Axon Enterprise, Inc $AXON

Key Points

• Moody Lynn & Lieberson LLC increased its holdings in Axon Enterprise, Inc by 24.2% in the second quarter, now owning shares valued at approximately $5,955,000.
• Other significant investors, including Jennison Associates LLC and Westfield Capital Management Co. LP, have also dramatically increased their positions during the first quarter, contributing to a total of 79.08% institutional ownership.
• Axon Enterprise posted an earnings report showing $2.12 earnings per share, exceeding analysts' estimates by $0.58, and experienced a 32.6% year-over-year revenue increase.

Moody Lynn & Lieberson LLC grew its position in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 24.2% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 7,192 shares of the biotechnology company's stock after purchasing an additional 1,403 shares during the quarter. Moody Lynn & Lieberson LLC's holdings in Axon Enterprise were worth $5,955,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. Jennison Associates LLC grew its stake in Axon Enterprise by 23,203.7% during the 1st quarter. Jennison Associates LLC now owns 614,053 shares of the biotechnology company's stock worth $322,961,000 after buying an additional 611,418 shares during the last quarter. Nuveen LLC acquired a new stake in Axon Enterprise in the first quarter worth about $264,796,000. Westfield Capital Management Co. LP boosted its holdings in Axon Enterprise by 29.8% in the first quarter. Westfield Capital Management Co. LP now owns 927,801 shares of the biotechnology company's stock worth $487,977,000 after acquiring an additional 212,931 shares in the last quarter. Vanguard Group Inc. increased its holdings in shares of Axon Enterprise by 2.2% during the first quarter. Vanguard Group Inc. now owns 8,632,008 shares of the biotechnology company's stock valued at $4,540,005,000 after acquiring an additional 185,571 shares in the last quarter. Finally, Axiom Investors LLC DE acquired a new position in shares of Axon Enterprise during the first quarter valued at about $93,088,000. 79.08% of the stock is owned by institutional investors and hedge funds.

Axon Enterprise Price Performance

NASDAQ:AXON opened at $708.84 on Monday. The firm's fifty day moving average is $758.60 and its two-hundred day moving average is $703.76. The firm has a market cap of $55.64 billion, a price-to-earnings ratio of 175.02, a PEG ratio of 27.53 and a beta of 1.40. The company has a debt-to-equity ratio of 0.63, a quick ratio of 2.71 and a current ratio of 2.95. Axon Enterprise, Inc has a one year low of $388.37 and a one year high of $885.91.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its quarterly earnings data on Monday, August 4th. The biotechnology company reported $2.12 earnings per share for the quarter, beating analysts' consensus estimates of $1.54 by $0.58. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The business had revenue of $668.54 million during the quarter, compared to analyst estimates of $641.77 million. During the same quarter last year, the business posted $1.20 EPS. The company's revenue was up 32.6% on a year-over-year basis. Axon Enterprise has set its FY 2025 guidance at EPS. Research analysts expect that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Insider Buying and Selling

In related news, CFO Brittany Bagley sold 870 shares of the business's stock in a transaction on Monday, September 15th. The shares were sold at an average price of $773.25, for a total value of $672,727.50. Following the completion of the transaction, the chief financial officer directly owned 113,022 shares in the company, valued at $87,394,261.50. The trade was a 0.76% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, President Joshua Isner sold 15,919 shares of the stock in a transaction on Friday, August 15th. The stock was sold at an average price of $746.26, for a total transaction of $11,879,712.94. Following the sale, the president directly owned 238,379 shares in the company, valued at $177,892,712.54. This trade represents a 6.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 44,932 shares of company stock valued at $34,408,816 in the last three months. 5.70% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several research firms have weighed in on AXON. UBS Group reissued a "neutral" rating and set a $840.00 target price (up previously from $820.00) on shares of Axon Enterprise in a research report on Tuesday, August 5th. Craig Hallum raised shares of Axon Enterprise from a "hold" rating to a "buy" rating and set a $900.00 price objective on the stock in a report on Tuesday, August 5th. Needham & Company LLC restated a "buy" rating and issued a $870.00 target price on shares of Axon Enterprise in a research note on Wednesday, September 24th. Northland Securities set a $800.00 price target on Axon Enterprise in a research note on Tuesday, August 5th. Finally, Morgan Stanley set a $885.00 price objective on Axon Enterprise and gave the company an "overweight" rating in a report on Friday, July 11th. Fourteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $841.64.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.